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Background and aims: fluid resuscitation of severely injured patients has shifted over the 
last decade toward less crystalloids and more blood products. helsinki university trauma 
center implemented the massive transfusion protocol in the end of 2009. The aim of the study 
was to review the changes in fluid resuscitation and its influence on outcome of severely 
injured patients with hemodynamic compromise treated at the single tertiary trauma center.
Material and Methods: data on severely injured patients (new injury severity score > 15) 
from helsinki university hospital trauma center’s trauma registry was reviewed over 
2006–2013. The isolated head-injury patients, patients without hemodynamic compromise 
on admission (systolic blood pressure > 90 or base excess > –5.0), and those transferred in 
from another hospital were excluded. The primary outcome measure was 30-day in-hospital 
mortality. The study period was divided into three phases: 2006–2008 (pre-protocol, 146 
patients), 2009–2010 (the implementation of massive transfusion protocol, 85 patients), 
and 2011–2013 (post massive transfusion protocol, 121 patients). expected mortality was 
calculated using the Revised injury severity classification score ii. The standardized 
mortality Ratio, as well as the amounts of crystalloids, colloids, and blood products (red 
blood cells, fresh frozen plasma, platelets) administered prehospital and in the emergency 
room were compared.
Results: Of the 354 patients that were included, standardized mortality Ratio values 
decreased (indicating better survival) during the study period from 0.97 (pre-protocol), 0.87 
(the implementation of massive transfusion protocol), to 0.79 (post massive transfusion 
protocol). The amount of crystalloids used in the emergency room decreased from 3870 ml 
(pre-protocol), 2390 ml (the implementation of massive transfusion protocol), to 2340 ml 
(post massive transfusion protocol). in these patients, the blood products’ (red blood cells, 
fresh frozen plasma, and platelets together) relation to crystalloids increased from 0.36, 
0.70, to 0.74, respectively, in three phases.
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Conclusion: during the study period, no other major changes in the protocols on treatment 
of severely injured patients were implemented. The overall awareness of damage control 
fluid resuscitation and introduction of massive transfusion protocol in a trauma center has 
a significant positive effect on the outcome of severely injured patients.
Key words: Multiple trauma; hemorrhage; blood transfusion; fluid therapy; mortality; quality control; trauma 
centers
InTRODUCTIOn
Uncontrolled bleeding remains the leading cause of 
potentially preventable deaths after severe trauma 
(1–3). Hemorrhagic shock and exsanguination account 
for about 50% of deaths in the first 24 h after injury (4, 
5). About one-third of bleeding trauma patients pre-
sent with coagulopathy on admission (6), which is 
associated with a fourfold or greater increase in mor-
tality (7, 8).
The strategy of fluid resuscitation in severely 
injured patients requiring massive transfusion (MT) 
has been changing over the last decade. High volume 
fluid resuscitation with crystalloids has been replaced 
with damage control resuscitation (DCR). This DCR 
approach consists of avoidance of hypothermia, per-
missive hypotension (systolic blood pressure (sBP) 
targeted at 90 mmHg in bleeding patients without 
head injury), the immediate administration of blood 
products (packed red blood cells (PRBC), fresh frozen 
plasma (FFP), and platelets), avoidance of crystalloids 
and colloids, and damage control surgery or angioem-
bolization to treat the cause of bleeding (9–13).
Along with the evolvement of DCR, many trauma 
centers have implemented pre-defined protocols of 
MT for trauma patients suffering major hemorrhage, 
which can be defined as “the loss of a patients’ total 
blood volume in less than 24 h” (14) or, more practi-
cally in the acute trauma setting, “an estimated blood 
transfusion volume of over four units in the initial 
2–4 h” (9). The term “massive transfusion” is mostly 
used for ≥10 U PRBC within 24 h (15), alternatively ≥10 
U PRBC within 6 h (16). DCR and massive transfusion 
protocols (MTPs) have been associated with improved 
survival in severely injured patients (7, 17–19).
The MTP was implemented at the end of 2009 in the 
Helsinki University trauma center. The aim of the pre-
sent study was to review the changes in fluid resusci-
tation and its influence on outcome of severely injured 
patients with hemodynamic compromise treated at 
the single tertiary trauma center.
MATERIAL AnD METHODS
TRAUMA UnIT AnD TRAUMA REGISTRy OF 
HELSInKI UnIVERSITy HOSPITAL
In Southern Finland, the treatment of severe blunt 
injuries of adult patients (>16 years) is centralized to 
Helsinki University trauma center (HU trauma center), 
which is one of Europe’s largest trauma centers treat-
ing 400–450 severely injured (Injury Severity Score 
(ISS) > 15) adult patients annually (children under the 
age of 16 and patients with penetrating body injuries 
are treated at a different location within the Helsinki 
University Hospital). The catchment area of the desig-
nated trauma center includes approximately 2 million 
inhabitants. So far, the  HU trauma center is the only 
hospital with a trauma registry in Finland, the Trauma 
Registry of Helsinki University Hospital (TR-THEL). 
All trauma admissions to the  HU trauma center from 
1 January 2006 onwards have been reviewed by three 
trauma nurses, and all patients with new Injury 
Severity Score (nISS) over 15 have been entered into 
the registry.
MTP In THE TRAUMA UnIT OF HELSInKI 
UnIVERSITy HOSPITAL
MTP was implemented in the  HU trauma center at 
the end of 2009. The activation criteria were defined as 
sBP < 90 mmHg and/or no radial pulse according to 
pre-notification call or sBP < 90 mmHg and/or no 
radial pulse or suspicion of massive hemorrhage on 
arrival at the  HU trauma center. The first emergency 
transfusion package (ETP) contains four units of PRBC 
(O–) and four units of FFP (AB). From the second ETP 
onwards, also one unit of platelets (which contains 
platelets from four donors) is included in addition to 
four units of PRBC and four units of FFP 
(PRBC:FFP:platelets ratio 1:1:1). The MTP in the  HU 
trauma center is shown in Table 1.
PATIEnT InCLUSIOn
We included all patients with severe injury (defined as 
an nISS > 15) treated in emergency room (ER) and 
entered into the TR-THEL between 1 January 2006 and 
31 December 2013. Patients dead on arrival, trans-
ferred in from another hospital, with burn injury, with 
isolated head injury, without hemodynamic compro-
mise on arrival (defined as sBP > 90 mmHg or base 
excess (BE) > –5.0 mmol/L on arrival), or with missing 
data for Revised Injury Severity Classification II (RISC 
II) calculations were excluded.
DATA AnALySIS
The study period was divided into three phases: 2006–
2008 (pre-protocol), 2009–2010 (the implementation of 
MTP), and 2011–2013 (post MTP). The subgroups of 
the patients were formed accordingly.
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The primary outcome measure was death in hospi-
tal within 30 days from admission. For each subgroup, 
expected mortality (using the prognoses derived from 
the RISC II (20)) and Standardized Mortality Ratio 
(SMR) were calculated. SMR is defined as the ratio of 
the observed mortality rate divided by the expected 
mortality rate. SMR values over 1 (higher observed 
than predicted mortality) indicate a poorer than aver-
age quality of care, and SMR values under 1 (higher 
predicted than observed mortality) a better than aver-
age care. The SMR is presented with its 95% confi-
dence interval.
For each subgroup, prehospital fluids and timings, 
the first recorded values of partial thromboplastin 
time (PTT), BE and hemoglobin on admission, and the 
amounts of crystalloids, colloids, PRBC, FFP, platelets, 
and total volume of fluids given in the ER were calcu-
lated. The volumes were adjusted to nearest 10 mL. 
Furthermore, the blood products’ (PRBC, FFP, and 
platelets) relation to crystalloids and FFP’s relation to 
PRBC were calculated. Patients who were not given 
any PRBC in the ER were identified.
For the statistical analyses, SPSS statistical software 
was used (IBM Corp., Version 20.0. Armonk, ny, 
USA). Differences between the pre-phase and the 
post-phase were evaluated with Pearson’s Chi-
squared test and Mann-Whitney U-test for categorical 
and continuous measurements, respectively. Statistical 
comparisons with the intermediate phase were not 
performed. Categorical variables are presented as per-
centages with number of cases, and continuous varia-
bles are presented as mean, standard deviation. 
Median values have been added where appropriate. 
The study protocol was approved by TR-THEL’s 
administrative board.
RESULTS
A total of 354 patients were included (Fig. 1). The 
numbers of the patients in the subgroups were 147 
(pre-protocol), 86 (at implementation of MTP), and 
121 (post MTP). There were no relevant differences in 
patient characteristics between the groups (Table 2). A 
slight trend of decreasing volume of prehospital-
administered fluids was noticed. The prehospital time 
(minutes from dispatch call to arrival to hospital) and 
the coagulation status on arrival (the first measured 
PTT, BE, and hemoglobin) remained steady (Table 3). 
TABLE 1
Massive Transfusion Protocol in Helsinki University trauma center (for adult patients).
Emergency transfusion package (ETP) PRBC FFP Platelets
ETP start (ready when the patient arrives) 4 (O–) 4 (AB) no
Trauma leader makes the decision on whether to continue MTP
ETP 2 (second package) 4 (O–) 4 (AB) 1 (4 donors) (O+)
ETP 3 (third package) 4 (group-specific) 4 (group-specific) 1 (4 donors) (O+)
ETP 4 (fourth package) 4 (group-specific) 4 (group-specific) 1 (4 donors) (group-specific)
… … … …
MTP is continued, until it is called off.
The reason for terminating the MTP: massive hemorrhage is ceased or the treatment is called off.
PRBC: packed red blood cells; FFP: fresh frozen plasma; MTP: massive transfusion protocol.
Fig. 1. Flow diagram of included and excluded patients in outcome analysis (multiple reasons for exclusion could apply).
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Also, the distribution of Abbreviated Injury Scale 
(AIS) ≥ 2 injuries in different body regions was 
observed to be comparable during the study period 
(Fig. 2).
There was a slight trend of decreasing ER time (the 
time from arrival to hospital to departure from the ER) 
during the three time periods. The percentage of 
patients undergoing emergency bleeding-control 
operations decreased during the study period. The 
amount of crystalloids used in the emergency depart-
ment decreased from 3870 mL (pre-protocol), 2390 mL 
(implementation), to 2340 mL (post MTP). The use of 
colloids was relatively minimal in general and also 
showed a decreasing trend during the study period 
(370, 330, and 140 mL, respectively). The overall blood 
products’ (PRBC, FFP, and platelets together) relation 
to crystalloids increased from 0.36, 0.70, to 0.74, respec-
tively (Table 4). The percentage of patients receiving 
no PRBC in the ER was 47.9 (70/147, pre-protocol), 
45.9 (39/86, implementation), and 51.2 (62/121, post 
MTP) (Table 5).
There was a decrease in three steps in the observed 
crude mortality (26.5% (39/147), 18.6% (16/86), and 
15.7% (19/121), respectively). More importantly, the 
SMR values (the ratio between observed and expected 
mortality) also decreased in three steps, indicating 
better survival during the study period from 0.97 (pre-
protocol), 0.87 (implementation), to 0.79 (post MTP) 
(Table 6).
DISCUSSIOn
We reviewed the evolvement of fluid resuscitation 
and its effect on mortality at the single tertiary trauma 
center, and noted better survival of hemodynamically 
unstable patients along with the implementation of 
MTP. During the study period, blood products’ rela-
tion to crystalloids and FFP’s relation to PRBC 
increased and the volume of fluids administered pre-
hospital decreased indicating adaptation of the princi-
ples of damage control fluid resuscitation in the 
treatment of bleeding in severely injured patients.
In the  HU trauma center, the MTP was imple-
mented in the end of 2009. However, the education 
and discussion concerning MTP had already started 
months before and this likely has influenced the deci-
sions made in the fluid resuscitation of hemodynami-
cally compromised patients before the official 
implementation of the MTP; this is why we decided to 
also cover the patients from the beginning of 2009 in 
the “implementation”-subgroup. It also allows for the 
full adaptation of a novel major implementation; thus 
we decided to consider the year 2010 as continued 
“implementation.”
The treatment of a severely injured patient is multi-
factorial. Thus, evolvements in all the fields of care, 
resources, and facilities have an impact. In the present-
ing center, no other major changes on the protocols in 
the treatment of severely injured patients emerged 
during the study period. Some changes, however, 
were made in the infrastructure of the emergency 
department: a new computed tomography (CT) scan 
with faster imaging capacity and easier access from 
the shock room was inaugurated in October 2008, and 
a new blood and fluid warmer with capacity for MT 
was deployed in January 2009 as a part of the MTP 
implementation. In addition, regular mortality and 
morbidity meetings on the treatment of severely 
TABLE 2
Patient characteristics. Continuous values are presented as mean/median (SD).
2006–2008 pre-protocol 2009–2010 implementation 2011–2013 post MTP p-value pre vs post
n 147 86 121  
Age (years) 39.0/36 (17.7) 41.9/36 (22.1) 42.2/41 (20.5) 0.196
Age ⩾ 60 years, % 19, 12.9% 22, 25.6% 28, 23.1% 0.036
Sex (male), % 113, 76.9% 57, 66.3% 84, 69.4% 0.211
ASA 3 or 4, %a 1 (of 39), 2.6% 5, 6.2% 9, 7.6% 0.453
Penetrating injury, % 2, 1.4% 0, 0% 0, 0% 0.503
ISS 33.6/29 (13.7) 33.6/29 (13.3) 32.1/29 (13.6) 0.386
nISS 39.3/34 (15.4) 39.2/37 (12.4) 39.2/34 (14.8) 0.954
MTP: massive transfusion protocol; ISS: Injury Severity Score; nISS: new Injury Severity Score; ASA: American Society of 
Anesthesiologists Physical Status Classification System.
aASA is available only in a small subgroup of patients in 2006–2008 (n = 39).
TABLE 3
Prehospital fluids and time (minutes from dispatch call to arrival to hospital), first measured partial thromboplastin time (PTT), base excess and 
hemoglobin on arrival. Mean/median (SD).
2006–2008 pre-protocol 2009–2010 implementation 2011–2013 post MTP p-value pre vs post
Prehospital fluids (mL) 1420/1000 (940) 1340/1000 (690) 1130/1000 (680) 0.007
Prehospital time (min) 72/63 (34) 77/74 (34) 67/64 (28) 0.766
PTT, % 73/73 (28) 76/76 (27) 75/76 (26) 0.322
Base excess, mmol/L −7.3/−6.8 (4.4) −6.5/−6.4 (3.5) −7.6/−6.5 (4.7) 0.772
Hemoglobin, g/L 109/114 (29) 112/111 (25) 115/117 (22) 0.129
MTP: massive transfusion protocol.
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injured patients were commenced in november 2008. 
These changes might also partly explain the better sur-
vival of the severely injured patients over the years.
Studies based on conventional fluid resuscitation 
guidelines investigating the effect of plasma:PRBC 
ratios on mortality have been recognized to involve 
survivorship bias to favor a positive outcome for high 
FFP:PRBC ratio. It has been considered that patients 
who died early never had the chance to receive 
sufficient FFP to match the number of PRBC units 
transfused (21). In our study, after implementing the 
MTP in the HU trauma center, already the first ETP 
Fig. 2. Injury distribution. Percentage of register’s patients having injuries (AIS ⩾ 2) in head, thorax, abdomen, pelvis, or upper/lower 
extremity is shown.
TABLE 4
In-hospital fluid resuscitation, ER time, emergency operations/angioembolization for hemorrhage. Mean/median (SD).
2006–2008 pre-protocol 2009–2010 implementation 2011–2013 post MTP p-value pre vs post
Crystalloids, mL 3870/3000 (2600) 2390/2000 (1240) 2340/2000 (1700) <0.001
Colloids, mL 370/0 (490) 330/0 (440) 140/0 (310) <0.001
PRBC, mL 1210/300 (1730) 1050/600 (1600) 1060/0 (1590) 0.455
FFP, mL 270/0 (570) 470/0 (820) 460/0 (770) 0.037
Platelets, mL 120/0 (310) 120/0 (250) 110/0 (300) 0.495
Total volume, mL 5890/4500 (4800) 4370/3500 (3480) 4110/3000 (3720) <0.001
Blood products/crystalloids 0.36/0.13 0.70/0.30 0.74/0.15 0.151
FFP/PRBC 0.18/0.14 0.44/0.43 0.40/0.42 <0.001
ER time, min 170/159 (88) 166/165 (73) 152/140 (73) 0.126
Emergency operations/
angioembolization for 
hemorrhage control, % (n)
10.2% (15) 3.5% (3) 4.1% (5) 0.060
MTP: massive transfusion protocol; FFP: fresh frozen plasma; ER: emergency room; PRBC: packed red blood cells.
TABLE 5
The percentage of patients requiring red blood cell transfusion in the emergency department.
2006–2008 pre-protocol 2009–2010 implementation 2011–2013 post MTP p-value pre vs post
no PRBC, % (n) 47.9% (70) 45.9% (39) 51.2% (62) 0.773
1–2 units, % (n) 8.9% (13) 9.4% (8) 9.9% (12)  
>2 units, % (n) 43.5% (64) 45.3% (39) 38.9% (47)  
MTP: massive transfusion protocol; PRBC: packed red blood cells.
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includes four units of FFP and four units of PRBC (1:1 
ratio) and, thus, the possibility of survivorship bias is 
reduced. Plasma administration has been associated 
with a substantial increase in complications, in partic-
ular Acute Respiratory Distress Syndrome (ARDS), 
with no improvement in survival in patients who do 
not require MT (<10 U PRBC within 12 h of admission) 
(22). This is why some trauma centers start FFP trans-
fusion only after six PRBCs to make sure the patient 
really needs MT.
This study has several limitations. First, as in all 
registry studies, the quality of the data must be con-
sidered. In TR-THEL three dedicated and trained 
trauma register nurses collect and code the data from 
a single trauma center into a hospital registry, which 
could be considered to limit the amount of erroneous 
data input. Second, we were limited to using in-hospi-
tal mortality as the primary end point. The effect of the 
evolvement of fluid resuscitation in correcting the 
possible trauma-induced coagulopathy was not exam-
ined. In a recent international multicenter clinical 
study, it was noted that the DCR and MTP strategies 
applied in three trauma centers did not consistently 
correct coagulopathy during hemorrhage (23). Third, 
the included patients (with possible hemodynamic 
compromise) were defined as sBP < 90 mmHg on 
arrival and/or first measured BE < –5.0 mmol/L in the 
ER. While sBP of 90 mmHg is commonly used to 
define both hypotension and shock (9), it may well 
also be present without severe bleeding. Furthermore, 
though low BE is associated with marked bleeding 
(24), low values can also be present for example in the 
case of hypoventilation or heavy alcohol load in the 
blood. This is reflected in the percentage of the patients 
(around 50%) who were not given any PRBC in the ER 
despite the definition of “hemodynamic compromise” 
used in this study, that is, “shock” was due to some 
other reason than bleeding. Fourth, the evolution of 
DCR to include permissive hypotension may reflect in 
sBP on arrival. The amount of patients with a similar 
“bleeding profile” may arrive to the ER with lower 
sBP than before the adaptation of the concept of per-
missive hypotension in the prehospital system.
The fluid resuscitation of trauma patients with 
major hemorrhage has evolved over the years. The 
adaptation of DCR strategies and implementation of 
MTP have improved survival of these patients. Much 
of this improvement has been attributed to increased 
plasma and platelet to PRBC ratios (25, 26). In addi-
tion to this, the better results over the years in the HU 
trauma center might also partly be due to improved 
knowledge and skills in damage control surgery and 
angioembolization in the case of uncontrolled bleed-
ing. However, the number of patients needing emer-
gency operations or angioembolization to control 
massive bleeding decreased during the years. This 
might be due to a decreased number of less severe 
bleedings not manifesting into severe ones because 
of enhanced coagulation status. Another reason 
could be the lower absolute number of injuries lead-
ing to major hemorrhage. However, the coagulation 
status on arrival and the percentage of thoraco-
abdominal or extremity AIS ≥ 2 injuries remained 
steady during the study period; only the percentage 
of patients sustaining pelvic injuries slightly 
decreased. This might indicate enhanced fluid resus-
citation as the reason for diminished need for bleed-
ing-control interventions.
TABLE 6
Observed 30-day mortality, expected mortality based on the RISC II (Revised Injury Severity Classification) prognosis, and Standardized Mortality 
Ratio (SMR) with 95% confidence interval.
2006–2008 pre-protocol 2009–2010 implementation 2011–2013 post MTP p-value pre vs post
30-day mortality, % (n) 26.5% (39) 18.6% (16) 15.7% (19) 0.032
Expected mortality (RISC II) 27.4% 21.4% 20.0% 0.113
MTP: massive transfusion protocol.
The effect of evolving fluid resuscitation on outcome 115
We noted a relatively low number of trauma 
patients with major hemorrhage over 8 years. Thus, 
ongoing education and simulation concerning DCR 
strategies is needed in order to keep up and to further 
improve the results. Also, along with studies indicat-
ing improved survival with the use of antifibrinolytic 
medication (27–30), tranexamic acid has become rou-
tine in prehospital treatment and will be added in the 
MTP of the HU trauma center. The future direction in 
the treatment of trauma patients with major hemor-
rhage is toward goal-directed hemostatic resuscitation 
with thromboelastometry to guide the transfusion. 
Thromboelastometry was implemented in 2014 in the 
treatment protocol in the HU trauma center—the 
effect in the outcome results will be reviewed. 
Monitoring the effectiveness of created guidelines or 
changes made in the treatment protocols is an essen-
tial part of quality control of modern hospitals treating 
trauma patients.
COnCLUSIOn
The overall awareness of damage control fluid resusci-
tation and introduction of MTP in a trauma center has 
a significant positive effect on the outcome of severely 
injured patients.
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